Oncolytics Biotech, Inc (NASDAQ:ONCY) does about 631.31K shares in volume on a normal day but saw 920303 shares change hands in the recent trading day. The company now has a market cap of 59.34M USD. Its current market price is $0.67, marking an increase of 4.31% compared to the previous close of $0.64. The 52 week high reached by this stock is $1.53 whilst the lowest price level in 52 weeks is $0.33.
The consensus objective for the share price is $3.79, suggesting that the stock has a potential upside of 82.32% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 06, 2022 when Maxim Group initiated the stock to “Buy” and issued a price target of $3.
The current price level is 51.61%, 33.03%, and -15.60% away from its SMA20, SMA50, and SMA200 respectively, with the ONCY price moving below the 50-day SMA on current market day. Oncolytics Biotech, Inc (ONCY) stock is up 56.46% over the week and 42.88% over the past month. Its price is -26.89% year-to-date and -35.14% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.08 and -0.35 for whole year.
To reach the target analysts have set, the stock logically needs to grow 82.32 percent from here.
The company has a return on investment of -453.37% and return on equity of -211.24%. The beta has a value of 0.77. Price to book ratio is 12.80.
